MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

K.J. Lenos, J.A.C.M. Goos, I.M. Vuist, S.H. den Uil, P.M. Delis-van Diemen, E.J.T. Belt, H.B.A.C. Stockmann, H. Bril, M. de Wit, B. Carvalho, S. Giblett, C.A. Pritchard, G.A. Meijer, Y. van Kooyk, R.J.A. Fijneman, S.J. van Vliet

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)26278-26290
JournalOncotarget
Volume6
Issue number28
DOIs
Publication statusPublished - 2015

Cite this